Detalles de la búsqueda
1.
Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial.
Gynecol Oncol
; 182: 7-14, 2024 Mar.
Artículo
Inglés
| MEDLINE | ID: mdl-38246047
2.
Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer.
Br J Cancer
; 129(11): 1841-1851, 2023 11.
Artículo
Inglés
| MEDLINE | ID: mdl-37821637
3.
Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study.
Gynecol Oncol
; 165(1): 97-104, 2022 04.
Artículo
Inglés
| MEDLINE | ID: mdl-35153073
4.
Incidence of postoperative thrombotic events in ovarian cancer patients with a de-escalated prophylactic strategy: A retrospective cohort study.
Gynecol Oncol
; 165(1): 75-81, 2022 04.
Artículo
Inglés
| MEDLINE | ID: mdl-35216810
5.
Functions of human liver CD69+CD103-CD8+ T cells depend on HIF-2α activity in healthy and pathologic livers.
J Hepatol
; 72(6): 1170-1181, 2020 06.
Artículo
Inglés
| MEDLINE | ID: mdl-31987989
6.
Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
J Allergy Clin Immunol
; 137(5): 1466-1476.e3, 2016 05.
Artículo
Inglés
| MEDLINE | ID: mdl-26824999
7.
Effects of 1alpha, 25-dihydroxyvitamin D3 on programmed cell death of Ishikawa endometrial cancer cells through ezrin phosphorylation.
J Obstet Gynaecol
; 37(4): 503-509, 2017 May.
Artículo
Inglés
| MEDLINE | ID: mdl-28421904
8.
Expression of p27 and Jun activation domain-binding protein 1 in endometriosis.
Arch Gynecol Obstet
; 292(2): 377-81, 2015 Aug.
Artículo
Inglés
| MEDLINE | ID: mdl-25666480
9.
Anti-4-1BB×PD-L1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD-1 Blockade.
Clin Cancer Res
; 2024 May 14.
Artículo
Inglés
| MEDLINE | ID: mdl-38743752
10.
Globally shared TCR repertoires within the tumor-infiltrating lymphocytes of patients with metastatic gynecologic cancer.
Sci Rep
; 13(1): 20485, 2023 11 22.
Artículo
Inglés
| MEDLINE | ID: mdl-37993659
11.
Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer.
Front Oncol
; 13: 1156973, 2023.
Artículo
Inglés
| MEDLINE | ID: mdl-37256181
12.
CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy.
Clin Cancer Res
; 29(9): 1794-1806, 2023 05 01.
Artículo
Inglés
| MEDLINE | ID: mdl-36716293
13.
Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D.
J Immunother Cancer
; 11(10)2023 10.
Artículo
Inglés
| MEDLINE | ID: mdl-37865397
14.
Social Efficiency of Public Transportation Policy in Response to COVID-19: Model Development and Application to Intercity Buses in Seoul Metropolitan Area.
Int J Environ Res Public Health
; 19(19)2022 09 23.
Artículo
Inglés
| MEDLINE | ID: mdl-36231361
15.
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial.
J Gynecol Oncol
; 33(2): e12, 2022 03.
Artículo
Inglés
| MEDLINE | ID: mdl-34910393
16.
Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer.
Cancers (Basel)
; 14(9)2022 May 06.
Artículo
Inglés
| MEDLINE | ID: mdl-35565437
17.
Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma.
Oncoimmunology
; 11(1): 2026019, 2022.
Artículo
Inglés
| MEDLINE | ID: mdl-35036078
18.
Risk of COVID-19 Infection in Public Transportation: The Development of a Model.
Int J Environ Res Public Health
; 18(23)2021 12 04.
Artículo
Inglés
| MEDLINE | ID: mdl-34886516
19.
Comparison of the Prognostic Outcome between High-Grade Ovarian Sertoli-Leydig Cell Tumors (SLCTs) and Low-Grade SLCTs.
Yonsei Med J
; 62(4): 366-369, 2021 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-33779091
20.
A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer.
Yonsei Med J
; 61(4): 284-290, 2020 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-32233170